This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Lütticken, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Lütticken, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2001, p. 1187-1189, Vol. 39, No. 3
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.3.1187-1189.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Antimicrobial Resistance of Streptococcus pneumoniae Recovered from Outpatients with Respiratory Tract Infections in Germany from 1998 to 1999: Results of a National Surveillance Study

Ralf René Reinert,* Smiljana Simic, Adnan Al-Lahham, Susanne Reinert, Maria Lemperle, and Rudolf Lütticken

Institute of Medical Microbiology, National Reference Center for Streptococci, University Hospital, D-52057 Aachen, Germany1

Received 13 October 2000/Returned for modification 18 November 2000/Accepted 11 December 2000

Clinically significant pneumococcal isolates were prospectively collected from outpatients with respiratory tract infections by 19 different clinical microbiology laboratories in Germany. Resistance rates in a total of 961 isolates were as follows: penicillin, 6.6%; clarithromycin, 10.6%; tetracycline, 13.9%; and levofloxacin, 0.1%. Among 324 isolates from children, pneumococcal serotypes 19F (17.0%), 23F (13.0%), and 6B (11.7%) were the predominant types.


* Corresponding author. Mailing address: Institute for Medical Microbiology, National Reference Center for Streptococci, University Hospital, Pauwelsstr. 30, D-52057 Aachen, Germany. Phone: 49 241 8088409. Fax: 49 241 8888483. E-mail: Reinert{at}rwth-aachen.de.


Journal of Clinical Microbiology, March 2001, p. 1187-1189, Vol. 39, No. 3
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.3.1187-1189.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Dogan, B., Schukken, Y. H., Santisteban, C., Boor, K. J. (2005). Distribution of Serotypes and Antimicrobial Resistance Genes among Streptococcus agalactiae Isolates from Bovine and Human Hosts. J. Clin. Microbiol. 43: 5899-5906 [Abstract] [Full Text]  
  • Reinert, R. R., Jacobs, M. R., Appelbaum, P. C., Bajaksouzian, S., Cordeiro, S., van der Linden, M., Al-Lahham, A. (2005). Relationship between the Original Multiply Resistant South African Isolates of Streptococcus pneumoniae from 1977 to 1978 and Contemporary International Resistant Clones. J. Clin. Microbiol. 43: 6035-6041 [Abstract] [Full Text]  
  • Reinert, R. R., van der Linden, M., Al-Lahham, A. (2005). Molecular Characterization of the First Telithromycin-Resistant Streptococcus pneumoniae Isolate in Germany. Antimicrob. Agents Chemother. 49: 3520-3522 [Abstract] [Full Text]  
  • Reinert, R. R., Reinert, S., van der Linden, M., Cil, M. Y., Al-Lahham, A., Appelbaum, P. (2005). Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003. Antimicrob. Agents Chemother. 49: 2903-2913 [Abstract] [Full Text]  
  • Reinert, R. R., Ringelstein, A., van der Linden, M., Cil, M. Y., Al-Lahham, A., Schmitz, F.-J. (2005). Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe. J. Clin. Microbiol. 43: 1294-1300 [Abstract] [Full Text]  
  • Kresken, M., Henrichfreise, B., Bagel, S., Brauers, J., Wiedemann, B. (2004). High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin. Antimicrob. Agents Chemother. 48: 3193-3195 [Abstract] [Full Text]  
  • Reinert, R. R., Muckel, S., Al-Lahham, A., Spratt, B. G., Brueggemann, A. B., Hakenbeck, R., Lutticken, R. (2003). Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing. J Med Microbiol 52: 981-987 [Abstract] [Full Text]  
  • Montanari, M. P., Cochetti, I., Mingoia, M., Varaldo, P. E. (2003). Phenotypic and Molecular Characterization of Tetracycline- and Erythromycin-Resistant Strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47: 2236-2241 [Abstract] [Full Text]  
  • Reinert, R. R., Lutticken, R., Bryskier, A., Al-Lahham, A. (2003). Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001. Antimicrob. Agents Chemother. 47: 489-493 [Abstract] [Full Text]  
  • Hamilton-Miller, J. M. T., Shah, S. (2002). Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes. J Antimicrob Chemother 50: 907-913 [Abstract] [Full Text]  
  • Amezaga, M. R., Carter, P. E., Cash, P., McKenzie, H. (2002). Molecular Epidemiology of Erythromycin Resistance in Streptococcus pneumoniae Isolates from Blood and Noninvasive Sites. J. Clin. Microbiol. 40: 3313-3318 [Abstract] [Full Text]  
  • Reinert, R. R., Al-Lahham, A., Lutticken, R., Boos, M., Schmitz, F.-J. (2002). Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones. J Antimicrob Chemother 49: 1015-1018 [Abstract] [Full Text]  
  • Reinert, R. R., Al-Lahham, A., Lemperle, M., Tenholte, C., Briefs, C., Haupts, S., Gerards, H. H., Lutticken, R. (2002). Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 49: 61-68 [Abstract] [Full Text]  
  • Reinert, R. R., Al-Lahham, A., Lutticken, R. (2001). In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. J Antimicrob Chemother 48: 279-281 [Abstract] [Full Text]